We serve Chemical Name:N-(piperidin-3-ylmethyl)cyclopropanamine CAS:1226016-69-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:N-(piperidin-3-ylmethyl)cyclopropanamine
CAS.NO:1226016-69-8
Synonyms:N-Cyclopropyl-3-piperidinemethanamine;Cyclopropyl-piperidin-3-ylmethylamine;HT1020
Molecular Formula:C9H18N2
Molecular Weight:154.25300
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:24.06000
Exact Mass:154.14700
LogP:1.45770
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-Cyclopropyl-3-piperidinemethanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,HT1020 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cyclopropyl-piperidin-3-ylmethylamine Use and application,HT1020 technical grade,usp/ep/jp grade.
Related News: Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. N-(piperidin-3-ylmethyl)cyclopropanamine manufacturer Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing. N-(piperidin-3-ylmethyl)cyclopropanamine supplier Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS. N-(piperidin-3-ylmethyl)cyclopropanamine vendor Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. N-(piperidin-3-ylmethyl)cyclopropanamine factory Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.
